Background: Immunoglobulin E (IgE) plays a central role in allergic disease. The B-cell receptor CD23 is pivotal in regulating IgE synthesis.
Results: Ca2+-dependent structural changes in CD23 enable additional interactions with IgE.
Conclusion: Mechanism for Ca2+-induced increase in affinity is revealed.
Significance: Ca2+ binding brings an extra degree of modulation to CD23 function.
Keywords: Allergy, Calcium, FC Receptors, Immunology, X-ray Crystallography, CD23, Immunoglobulin E
Abstract
Immunoglobulin E (IgE) antibodies play a fundamental role in allergic disease and are a target for therapeutic intervention. IgE functions principally through two receptors, FcϵRI and CD23 (FcϵRII). Minute amounts of allergen trigger mast cell or basophil degranulation by cross-linking IgE-bound FcϵRI, leading to an inflammatory response. The interaction between IgE and CD23 on B-cells regulates IgE synthesis. CD23 is unique among Ig receptors in that it belongs to the C-type (calcium-dependent) lectin-like superfamily. Although the interaction of CD23 with IgE is carbohydrate-independent, calcium has been reported to increase the affinity for IgE, but the structural basis for this activity has previously been unknown. We have determined the crystal structures of the human lectin-like head domain of CD23 in its Ca2+-free and Ca2+-bound forms, as well as the crystal structure of the Ca2+-bound head domain of CD23 in complex with a subfragment of IgE-Fc consisting of the dimer of Cϵ3 and Cϵ4 domains (Fcϵ3-4). Together with site-directed mutagenesis, the crystal structures of four Ca2+ ligand mutants, isothermal titration calorimetry, surface plasmon resonance, and stopped-flow analysis, we demonstrate that Ca2+ binds at the principal and evolutionarily conserved binding site in CD23. Ca2+ binding drives Pro-250, at the base of an IgE-binding loop (loop 4), from the trans to the cis configuration with a concomitant conformational change and ordering of residues in the loop. These Ca2+-induced structural changes in CD23 lead to additional interactions with IgE, a more entropically favorable interaction, and a 30-fold increase in affinity of a single head domain of CD23 for IgE. Taken together, these results suggest that binding of Ca2+ brings an extra degree of modulation to CD23 function.
Introduction
The prevalence of allergy is increasing worldwide (1). Allergic diseases include asthma, hay fever, and anaphylactic shock and are commonly triggered by environmental allergens, resulting in an inflammatory response. Immunoglobulin E (IgE) antibodies play a central role in the mechanism of allergic disease (2), binding allergen via its Fab regions and interacting with two very different cell surface receptors, FcϵRI and CD23 (also known as FcϵRII), via its Fc region.
The FcϵRI receptor is primarily expressed on mast cells, basophils, and antigen-presenting cells and binds IgE with a high affinity (KD ∼10−10 m). It is responsible for allergic sensitization and the immediate type I hypersensitivity reaction in which minute amounts of allergen cross-link receptor-bound IgE on mast cells and basophils, triggering cellular degranulation (2).
The second principal receptor for IgE, CD23, is a type II transmembrane glycoprotein with a C-type lectin-like domain (CTLD)4 (3, 4). It is expressed in several hematopoietic cell types, including B-cells and antigen-presenting cells.
In its membrane-bound form, CD23 consists of three CTLD “heads” connected to the membrane via a trimeric α-helical coiled-coil “stalk” (5). The stalk region is susceptible to attack by various proteases, such as ADAM10 (6, 7), releasing soluble forms of CD23. The house dust mite allergenic protease Der p I generates a soluble monomeric form of CD23 consisting of just the lectin head domain, termed derCD23 (8, 9).
The interaction between CD23 and IgE is critical in the regulation of IgE synthesis, which can be up- or down-regulated depending on the oligomerization state of CD23 (2, 9, 10). The interaction between the proteins is also crucial in facilitated antigen presentation (11).
CD23 is the only Ig receptor that belongs to the CTLD superfamily (3, 4). Some CTLDs interact with carbohydrate moieties of glycoproteins via a bound Ca2+ ion, but other CTLD-containing proteins bind neither Ca2+ nor carbohydrate and interact with other ligands such as proteins (4, 12). Ca2+ and carbohydrate binding activities are limited to those CTLDs that contain the appropriate sequence motifs (3). These CTLDs contain between one and three Ca2+-binding sites as follows: site 2 is usually involved in carbohydrate binding, and site 1 and site 3 commonly play structural roles (4). Sequence analysis suggests that the CTLD of human CD23 has two putative Ca2+-binding sites: a conserved “principal” binding site (site 2 in CTLD nomenclature) and a less well conserved “auxiliary” binding site (site 1) (3, 13).
Human CD23 binds via its CTLD to each chain of the IgE dimer, in a carbohydrate-independent manner (14, 15). Although Ca2+ is not required (14), despite an early report that murine CD23 binding to IgE was Ca2+-dependent (16), enhanced binding of human CD23 in the presence of Ca2+ has been reported (17). However, the role played by Ca2+ in IgE binding has hitherto been unknown.
The structure of derCD23 has been determined previously, both by NMR (17) and x-ray crystallography (13). The solution structure suggests that Ca2+ binds at the auxiliary binding site, but the derCD23 crystal structure, incorporating a double mutation (H213R and G256S), indicates that a single Ca2+ ion binds at the principal binding site. Surprisingly, the crystal structure revealed that “loop 4,” known to contribute to IgE binding (18), is substantially disordered in the presence of Ca2+ and ordered in its absence. We recently solved the structure of derCD23 in complex with Fcϵ3-4 (a subfragment of IgE-Fc consisting of the dimer of Cϵ3 and Cϵ4 domains) and found loop 4 partially disordered in the absence of Ca2+ (15). There are other precedents for the stabilizing effects of Ca2+ upon loop 4 in CTLDs (4), such as mannose-binding lectin (19).
We have studied the binding of Ca2+ to wild-type, human derCD23, and its effect upon IgE binding using site-directed mutagenesis, x-ray crystallography, ITC, surface plasmon resonance, and stopped-flow fluorescence analysis. We demonstrate that a single Ca2+ ion binds at the principal binding site in the CTLD head domain of CD23, inducing a trans to cis isomerization of Pro-250 in loop 4 and concomitant conformational changes in the rest of the loop. The additional salt bridges and hydrogen bonds formed between IgE and CD23 upon Ca2+ binding give rise to a more entropically favorable interaction and a 30-fold increase in affinity.
EXPERIMENTAL PROCEDURES
Site-directed Mutagenesis of derCD23
Mutations (E249A, S252A, D258A, N269A, N269D, or D270A) were introduced into the derCD23 gene using the QuikChange Lightning site-directed mutagenesis kit (Stratagene). The wild-type derCD23 gene, in a pET5a vector (17), was used as a template for PCR. The primers for PCR incorporating the derCD23 mutations were synthesized by Sigma (see supplemental Table S1). The resulting vectors were transformed into BL21 (DE3) competent cells.
Expression, Refolding, and Purification of Proteins
Wild-type and six mutant derCD23 proteins were all expressed, refolded, and purified according to protocols previously described (15, 17). Correct folding of the derCD23 proteins was assessed by one-dimensional 1H NMR at 500 MHz (large dispersion and strong signals of methyl groups between 1.0 and −1.0 ppm).
IgE-Fc (including domains Cϵ2, Cϵ3, and Cϵ4) and Fcϵ3-4 were prepared as described previously (15).
Surface Plasmon Resonance
Experiments were carried out on a Biacore T200 instrument (GE Healthcare). Specific binding surfaces were prepared by coupling derCD23 to a CM5 sensor chip via amine coupling. Coupling density was limited to <100 RU. Samples of Fcϵ2-4 (IgE-Fc) were dialyzed into either HBS/Ca (10 mm HEPES, pH 7.4, 150 mm NaCl, 4 mm CaCl2, 0.01% (v/v) surfactant P-20) or HBS/EDTA (10 mm HEPES, pH 7.4, 150 mm NaCl, 10 mm EDTA, 0.01% (v/v) surfactant P-20) and injected over the sensor chip at a flow rate of 25 μl min−1 at concentrations of 4000, 2000, 1000, 500, 250, 125, 62.5, 31.2, 15.6, 7.8, and 3.9 nm. Each data set was collected at 5, 15, 25, and 35 °C. Analyte concentrations were injected in duplicate, a titration series of “low-to-high” analyte concentration followed by a “high-to-low” series. A 2-min association phase was followed by a 5-min dissociation phase, which allowed complete dissociation of analyte from the senor surface. Standard double-referencing data subtraction methods were applied (20) before evaluation of equilibrium binding. Data were analyzed using curve-fitting software from Microcal Origin (OriginLab).
Crystallization
All crystals were obtained by the hanging drop vapor diffusion method at 291 K and grew to their maximal size within 2 weeks.
All of the derCD23 crystals were grown by mixing protein at 3.5 mg/ml in 25 mm Tris, pH 7.5, and 137 mm NaCl with an equal volume of reservoir solution. Wild-type and S252A mutant derCD23 crystals were obtained using 18.5% PEG 6000, 2% 1,6-hexanediol, 0.05 m ammonium sulfate, and 0.1 m sodium acetate, pH 4.7, as the reservoir solution. E249A mutant derCD23 crystals were grown using 0.2 m potassium thiocyanate, 0.1 m Bistris propane, pH 8.5, and 20% PEG 3350. Crystals of D258A derCD23 were obtained using 18% ethanol, 4% PEG 400, and 0.1 m sodium acetate, pH 5.0. D270A mutant derCD23 crystals were formed using 30% PEG 4000 and 0.3 m ammonium sulfate as the reservoir. The derCD23 crystals were cryoprotected by soaking in reservoir solution containing an additional 20% glycerol, and they were subsequently flash-cooled in liquid nitrogen.
Ca2+ was bound to wild-type derCD23 by soaking the crystals with 25% PEG 6000, 2% 1,6-hexanediol, 0.1 m MES, pH 7.1, 10 mm CaCl2, and 15% glycerol for 3 days. The crystals were then flash-cooled.
Crystals of the Ca2+-bound derCD23-Fcϵ3-4 complex were grown using 0.22 mm Fcϵ3-4 (11 mg/ml) and 0.44 mm derCD23 (6.8 mg/ml, in 20 mm Tris 7.5, 20 mm NaCl and 0.05% sodium azide) diluted with an equal volume of 0.2 m sodium acetate trihydrate, 0.1 m Tris, pH 8.5, 16% PEG 4000, and 10 mm CaCl2, and the drops were then micro-seeded with crystals of the “apo” Fcϵ3-4-derCD23 complex (15). The crystals were flash-cooled using 0.2 m sodium acetate trihydrate, 0.1 m Tris, pH 7.5, 16% PEG 4000, 15 mm CaCl, and 25% glycerol as cryoprotectant.
Crystallographic Data Collection and Processing
All diffraction data were collected at 100 K at the Diamond Light Source (Harwell, UK) or Daresbury SRS (Cheshire, UK) synchrotrons. Indexing, integration, and merging of data were carried out with the MOSFLM (21, 22) or HKL2000 (23) suite of programs.
Crystallographic Structure Determination
The derCD23 and Ca2+-bound derCD23- Fcϵ3-4 complex structures were solved by molecular replacement with PHASER (24) using the Ca2+-free derCD23 (PDB 2H2R) (13) and the derCD23- Fcϵ3-4 complex structures (PDB 4EZM) (15), respectively, as search models.
In the presence of a high degree of noncrystallographic symmetry, reflections were selected for the Rfree set in thin resolution shells (25) using SFTOOLS (26). Iterative cycles of refinement using REFMAC5 (27), PHENIX (28), and BUSTER-TNT (29) alternated with manual model building with COOT (30). During initial refinement, tight noncrystallographic symmetry restraints were used. These were gradually relaxed, and finally local structure similarity restraints (“local noncrystallographic symmetry”) (27, 29) were applied. TLS groups (31) were generated using the TLSMD web server (32). The crystallographic processing and refinement statistics are presented in Table 1.
TABLE 1.
Ca2+-bound derCD23 | Ca2+-free derCD23 | E249A derCD23 | S252A derCD23 | D258A derCD23 | D270A derCD23 | Ca2+-bound derCD23-Fcϵ3-4 | |
---|---|---|---|---|---|---|---|
PDB accession code | 4G9A | 4G96 | 4GI0 | 4GJ0 | 4GJX | 4GK1 | 4GKO |
Data processing statistics | |||||||
Beamline | DLS I03 | Daresbury 14.1 | DLS I03 | DLS I02 | DLS I03 | DLS I02 | DLS I04-1 |
Wavelength | 0.9763 Å | 1.4880 Å | 0.9763 Å | 0.9795 Å | 0.9763 Å | 0.9795 Å | 0.9173 Å |
Processing software | HKL2000 | HKL2000 | HKL2000 | HKL2000 | MOSFLM | HKL2000 | MOSFLM |
Space group | P1 | P1 | P4122 | P1 | P65 | P212121 | P212121 |
Unit cell parameters | a = 54.24 Å | a = 52.40 Å | a = 63.32 Å | a = 52.50 Å | a = 90.97 Å | a = 73.78 Å | a = 62.83 Å |
b = 53.71° | b = 56.73° | b = 63.32° | b = 56.87° | b = 90.97° | b = 109.11° | b = 110.13° | |
c = 56.64° | c = 62.20° | c = 261.42° | c = 62.68° | c = 351.68° | c = 139.00° | c = 367.41° | |
α = 112.92° | α = 68.49° | α = 68.06° | |||||
β = 88.53° | β = 88.16° | β = 88.23° | |||||
γ = 114.96° | γ = 73.40° | γ = 73.53° | |||||
No. of mol/a.u. | 4 | 4 | 3 | 4 | 8 | 7 | 9 |
Resolution rangea | 50.0 to 2.00 Å (2.07 to 2.00 Å) | 57.2 to 2.25 Å (2.37 to 2.25 Å) | 65.4 to 2.27 Å (2.40 to 2.27 Å) | 50.0 to 1.95 Å (2.02 to 1.95 Å) | 58.67 to 2.80 Å (2.95 to 2.80 Å) | 50.0 to 2.25 Å (2.33 to 2.25 Å) | 73.5 to 3.30 Å (3.48 to 3.30 Å) |
Observations | 139,591 | 82,009 | 323,278 | 97,210 | 133,827 | 382,280 | 157,453 |
Unique reflections | 34,591 | 28,279 | 25,713 | 45,157 | 36,967 | 54,601 | 33,757 |
Average redundancy | 4.0 (4.1) | 2.9 (2.9) | 12.6 (13.0) | 2.2 (2.1) | 3.6 (3.5) | 7.0 (6.7) | 4.7 (4.9) |
Completeness | 97.9% (96.9%) | 94.6% (86.7%) | 100% (100%) | 97.1% (93.7%) | 91.6% (94.3%) | 99.7% (99.5%) | 84.0% (86.3%) |
Wilson B-factor | 20.0 Å2 | 42.5 Å2 | 50.7 Å2 | 29.9 Å2 | 41.5 Å2 | 37.8 Å2 | 92.9 Å2 |
I/σ(I) | 20.5 (4.6) | 10.8 (3.6) | 12.9 (2.3) | 20.0 (2.0) | 7.0 (1.9) | 34.0 (4.0) | 5.1 (1.4) |
Rmergeb/Rp.i.m.c | 0.096b (0.406) | 0.065b (0.226) | 0.020b (0.359) | 0.049b (0.369) | 0.081c (0.400) | 0.078b (0.463) | 0.089c (0.501) |
Refinement statistics | |||||||
Resolution range | 38.8 to 2.00 Å | 39.4 to 2.25 Å | 65.6 to 2.27 Å | 31.3 to 1.95 Å | 78.8 to 2.80 Å | 43.9 to 2.24 Å | 183.7 to 3.30 Å |
Total no. of reflections | 34,538 | 26,856 | 24,325 | 45,141 | 35,034 | 54,533 | 31,969 |
No. of working reflections | 32,806 | 25,433 | 23,019 | 42,853 | 33,200 | 51,765 | 30,285 |
No. of test reflections | 1732 | 1423 | 1306 | 2288 | 1834 | 2768 | 1684 |
R factord | 0.155 | 0.176 | 0.207 | 0.169 | 0.210 | 0.183 | 0.275 |
Rworking | 0.152 | 0.173 | 0.205 | 0.166 | 0.208 | 0.181 | 0.272 |
Rfree | 0.205 | 0.236 | 0.251 | 0.212 | 0.251 | 0.226 | 0.312 |
No. of atoms | 4,697 | 4,571 | 3,328 | 4,710 | 8,810 | 8,120 | 16,217 |
Protein | 4,271 | 4,273 | 3,202 | 4,257 | 8,635 | 7,452 | 15,823 |
Otherse | 426 | 298 | 126 | 453 | 175 | 668 | 394 |
r.m.s. bond length deviation | 0.006 Å | 0.017 Å | 0.010 Å | 0.007 Å | 0.006 Å | 0.006 Å | 0.020 Å |
r.m.s. bond angle deviation | 0.963° | 1.944° | 1.375° | 1.031° | 0.987° | 0.937° | 1.963° |
Mean B factor | 25.7 Å2 | 41.3 Å2 | 31.6 Å2 | 40.4 Å2 | 51.0 Å2 | 43.5 Å2 | 150.5 Å2 |
Main chain | 22.3 | 39.1 | 30.5 | 37.0 | 50.5 | 40.8 | 148.8 |
Side chain | 29.1 | 43.6 | 32.6 | 43.7 | 51.5 | 46.1 | 152.1 |
Otherse | 35.5 | 44.4 | 46.3 | 48.2 | 32.5 | 53.5 | 163.6 |
r.m.s. backbone B factor deviationf | 2.4 | 2.0 | 1.1 | 2.9 | 1.0 | 2.3 | 3.5 |
Ramachandran statisticsg | |||||||
Favored | 96.2% | 94.1% | 93.7% | 96.0% | 95.3% | 95.5% | 90.9% |
Allowed | 100% | 99% | 99.5% | 99.8% | 99.9% | 100% | 99.1% |
Outliers | 0% | 1% | 0.5% | 0.2% | 0.1% | 0% | 0.9% |
a Values in parentheses are for the outer resolution shell.
b Rmerge = Σ|Iobs − 〈I〉|/Σ〈I〉.
c Rp.i.m. (precision-indicating merging R-factor) = Σhkl(1/(N − 1))1/2 Σi|Ii(hkl) − I(−h−k−l)|/ΣhklΣiIi(hkl) (49).
d R factor = Σhkl‖Fo(hkl)| − |Fc(hkl)‖/Σhkl|Fo(hkl)|.
e Ca2+ ions, carbohydrate, water molecules, SO42− ions and glycerol.
f Root mean square (r.m.s.) deviation between B-factors for bonded main chain atoms.
g Data are defined by MolProbity (50).
In the Ca2+-bound derCD23-Fcϵ3-4 complex crystal structure, no electron density was observed for the following: Fcϵ3-4 residues 387–388 of chain A; 362–364 of chain B; 367–371 and 421–428 of chain C; 365–367, 387–389, 454–458, 462–463, 481–483, and 525–526 of chain D; 367–370, 419–422, 429–430, 446–449, 479–480, and 510–519 of chain E; and 363–364 and 446–450 of chain F. Therefore, these residues were not built into the model. Carbohydrate atoms and six Ca2+ ions were subsequently incorporated into the structure. Because of the low resolution of the Ca2+-bound derCD23-Fcϵ3-4 complex data, B-factor sharpening (27, 28, 30) was used to improve the quality of the electron density maps, thereby helping to resolve the positions of the Ca2+ ions. All of the structural figures presented were generated using PyMOL (33).
Isothermal Titration Calorimetry
Wild-type and mutant derCD23 protein samples were initially dialyzed against 10 mm Tris, pH 6.8, 125 mm NaCl, 10 mm EDTA to remove the bound Ca2+ present from the protein refolding procedure. This was followed by extensive dialysis against 10 mm Tris, pH 6.8, 125 mm NaCl buffer pretreated with 50 g/liter Chelex 100. Freshly prepared 20 mm CaCl2 in the same batch of assay buffer used to dialyze the protein was titrated into 50 μm derCD23 proteins at 25 °C in an iTC200 microcalorimeter (Microcal, GE Healthcare). Data were analyzed using the Microcal Origin software supplied with the machine using a 1:1 binding model under “low c-value” conditions where the stoichiometry is fixed at 1:1 (as shown by the crystal structure), and the KD and ΔH values were floated.
Stopped-flow Analysis
Experiments were carried out using a single-mix SF-61SX stopped-flow fluorimeter (TgK Scientific Ltd.) with a 1:1 mixing ratio. Experiments were carried out at 25 °C in the same buffer as for the ITC (see above) with 2 μm apo-derCD23 mixed against 20 mm CaCl2 with or without preincubation with stoichiometric amounts of the prolyl isomerase cyclophilin A. Tryptophan fluorescence was excited at 296 nm and all fluorescence emission collected above 305 nm. Typically, 6–10 runs were averaged before fitting to a double exponential (Equation 1) using the manufacturer's analysis software,
where Fobs is the observed fluorescence change; Fn is the fluorescence amplitude for the nth transient; kobsn is the observed rate constant for the nth transient, and Fe is the end point fluorescence.
RESULTS
Binding Affinities and Thermodynamics for the IgE-Fc/derCD23 Interaction Are Strongly Affected by Calcium
The binding affinity of IgE-Fc for derCD23 is increased in the presence of Ca2+. The difference in binding affinity is highly temperature-dependent. At 5 °C, the difference in affinity is less than 2-fold (1.6 and 3.0 μm), but at 35 °C there is a 30-fold difference in binding affinity (2 and 58 μm) (Fig. 1 and supplemental Fig. S1). The thermodynamic parameters of the two interactions are also notably different, as shown in a van't Hoff plot of the binding thermodynamics (Fig. 1). In the presence of Ca2+, the IgE-Fc/derCD23 affinity shows only a small temperature dependence; for this interaction, a small favorable enthalpic contribution to binding is observed (Fig. 1), but the binding is largely driven by a favorable entropic term. In contrast, in the absence of calcium, the binding affinity of IgE-Fc/derCD23 is highly temperature-dependent (Fig. 1), consistent with a binding event largely driven by favorable enthalpy. The calcium-free binding event also shows a notable nonlinearity in the van't Hoff plot, indicating a significant ΔCp component for this interaction (Fig. 1).
Comparison of Ca2+-free and Ca2+-bound derCD23 Crystal Structures
The Ca2+-free and Ca2+-soaked derCD23 crystals both belong to space group P1 and have four molecules within the asymmetric unit (Table 1). Although the unit cells index differently, the derCD23 molecules pack in an almost identical arrangement in both crystal lattices.
The CTLD topology of all the derCD23 molecules is essentially identical, with Cα root mean square deviations ranging from 0.2 to 1.2 Å (over 120 Cα pairs) (for individual pairwise comparisons see supplemental Table S2). The structure consists of two α-helices and two β-sheets formed by eight β-strands with four disulfide bonds (Cys residues 160–288, 163–174, 191–282, and 259–273). Unlike previously solved derCD23 crystal structures (PDB codes 2H2R and 2H2T (13)), electron density for all the head domain is well observed, including loop 1 (Leu-226 to Glu-231) and loop 4 (Arg-253 to Glu-257) following earlier terminology (13). These loops are known to contribute to IgE binding (15, 18).
Comparison of the Ca2+-free and Ca2+-bound derCD23 structures reveals that the only conformational differences are in loop 4 and, to a lesser degree, in loop 1 (Fig. 2). Although the four copies of loop 4 in the Ca2+-bound structure adopt similar conformations, two copies of this loop in the Ca2+-free structure adopt a different conformation, and the other two adopt yet another (Fig. 2). These two different conformations of Ca2+-free derCD23 are not the result of different crystal packing interactions. In Ca2+-free “conformation 1,” two principal binding site residues (Glu-249 and Asp-270) are in a similar position to that observed in the Ca2+-bound structure, although the orientation of the Thr-251 side chain is different. In Ca2+-free “conformation 2,” only Glu-249 remains in a similar position when compared with the Ca2+-bound structure, although marked differences are seen for both Thr-251 (Fig. 3) and Asp-270.
Residues 249–251 in particular (the Glu-Pro-Thr, EPT, motif) are distinctly different between the Ca2+-bound and Ca2+-free derCD23. In the Ca2+-bound structure, Pro-250 adopts a cis configuration in all four copies (Fig. 3), and the distance between Thr-251 (Oγ1) and Glu-249 (Oϵ1) is 3.7 Å. In the Ca2+-free structure, this distance is 6.1 Å in conformation 1 and 8.3 Å in conformation 2; Pro-250 is cis in the former and trans in the latter.
These two possible configurations of Pro-250 in the absence of Ca2+ have an effect upon adjacent residues. The trans configuration of Pro-250 forms two hydrogen bonds with Arg-253, whereas cis Pro-250 cannot; consequently, both Arg-253 and Ser-254 are disordered when Pro-250 is cis (conformation 1), but are ordered, with Arg-253 pointing into a cavity between loops 1 and 4 (supplemental Fig. S2), when Pro-250 is trans (conformation 2). In the presence of Ca2+, Pro-250 is effectively locked into the cis configuration.
Ca2+ Binds in the Principal Evolutionarily Conserved Binding Site of CD23
Unlike MBL (34) and DC-SIGN (35) that bind two and three Ca2+ ions, respectively, Ca2+-soaked human derCD23 crystals reveal that a single Ca2+ ion binds at the principal binding site in all four molecules of the asymmetric unit (Fig. 4). The electron density for the Ca2+-coordinating ligands (Glu-249, Thr-251, Asp-270, and three water molecules) and the Ca2+ ion itself is well defined in three of the derCD23 molecules; electron density for the three water molecules and Thr-251 in the fourth molecule is unclear. Although the site of Ca2+ binding is consistent with the observations of Wurzburg et al. (13), the details of the coordination of Ca2+ differ from that reported by them for the double mutant (H213R/G256S) human derCD23 crystal structure (PDB code 2H2T).
In the wild-type Ca2+-bound derCD23 crystal structure presented here, three residues (Glu-249, Thr-251, and Asp-270) provide four oxygen atoms, and three water molecules provide a further three for the binding of Ca2+ (Fig. 4). The coordination geometry is pentagonal bipyramidal formed by the seven ligands. This differs from the pentagonal bipyramidal coordination with one bisected apex formed by eight ligands, as seen in MBL (34), DC-SIGN (35), and human asialoglycoprotein receptor-1 (ASGPR-I) (36).
Surprisingly, in contrast to Wurzburg et al. (13), we found that the highly conserved Asn-269 residue (3, 13) is not directly involved in the binding of Ca2+; the nitrogen atom of the carboxamide group was found to form a hydrogen bond with a water molecule that acts as a Ca2+ ligand (Fig. 4). Additionally, we found that three water molecules, not two as previously suggested (13), directly ligate Ca2+.
To verify that the principal site is indeed the location of Ca2+ binding to derCD23 in solution, and to confirm the exact nature of the interaction, several single point mutations in derCD23 were generated: conserved residues (3, 13) were mutated within the principal (E249A and D270A) and auxiliary (S252A and D258A) calcium-binding sites, along with the highly conserved Asn-269 residue (N269A and N269D). The ability of wild-type and mutant derCD23 to bind calcium was assessed by ITC (Table 2 and supplemental Fig. S3).
TABLE 2.
Ca2+-binding site | Construct | Binding affinity (KD) |
---|---|---|
Wild type derCD23 | 1.5 mm | |
Principal | E249A | Not measurable |
Principal | D270A | Not measurable |
Auxiliary | S252A | 1.5 mm |
Auxiliary | D258A | Not measurable |
N269A | 0.73 mm | |
N269D | 1.5 mm |
Wild-type derCD23 was found to have a KD for Ca2+ of 1.5 mm. This agrees with a previously calculated affinity determined by NMR perturbation studies (17). As expected, the two principal binding site derCD23 mutants, E249A and D270A, were unable to bind Ca2+.
As predicted from the crystal structure, the introduction of the S252A mutation did not affect Ca2+ binding, but unexpectedly, the D258A mutant was unable to bind Ca2+ even though the aspartate forms part of the apparently nonfunctioning auxiliary Ca2+-binding site.
The N269A and N269D mutants retained the ability to bind Ca2+, consistent with our observation that Asn-269 is not directly involved in Ca2+ ligation. In fact, the affinity of the N269A mutant for Ca2+ is 2-fold higher.
Principal and Auxiliary Ca2+-binding Site Mutant derCD23 Structures
The crystal structures of the derCD23 principal and auxiliary Ca2+-binding site mutants were determined (but not those of N269A or N269D mutants) (supplemental Fig. S4).
The S252A auxiliary binding site mutant crystallized in the same conditions and same crystal form as wild-type Ca2+-free derCD23. Similarly, Pro-250 is trans in two copies and cis in the others. D258A (auxiliary) and D270A (principal site) crystallized differently, and in all eight and seven molecules within the asymmetric unit, respectively, Pro-250 is trans. In contrast the E249A (principal site) mutant, which crystallized in yet another form, has cis Pro-250 in all three independent copies. Here also, loop 4 adopts a similar conformation to that observed in the Ca2+-bound derCD23 structure (and conformation 2 of the Ca2+-free and S252A structures). Mutation of the adjacent Glu-249, part of the EPT motif, to alanine appears to have locked Pro-250 into the cis configuration. Thus, of the 30 independent copies of derCD23 presented here, 19 are trans; of the remaining 11, four are cis as a result of the Ca2+ present, and 3 are cis as a result of mutation of the adjacent Glu-249. Thus, trans is apparently favored in the absence of Ca2+ or other factors.
No major conformational changes were observed in either the principal or auxiliary Ca2+-binding sites upon introduction of the point mutations that could inadvertently affect the binding of Ca2+, with the exception of D258A. Mutation of Asp-258, which faces Pro-250 at the base of loop 4, to alanine results in a conformational change in loop 4 and a reorientation of Arg-253 compared with the Ca2+-free derCD23 structure; this was seen in all eight molecules within the asymmetric unit. The side chain of Arg-253 flips ∼180° and projects into the principal Ca2+-binding site cavity, occupying the Ca2+ ion position (supplemental Fig. S5). The re-positioned Arg-253 side chain forms two salt bridges with the carboxylate group of Glu-249. Occupation of the Ca2+-binding site by Arg-253 explains why the D258A mutant fails to bind Ca2+.
Intriguingly, in the previously determined Ca2+-free crystal structure of the double-mutant derCD23 (13), loop 4 becomes ordered in the absence of Ca2+ because of a similar rearrangement of the side chain of Arg-253, which again occupies the Ca2+-binding site. In that study, however, the conformation of loop 4 and the orientation of Arg-253 is likely due to the nonsilent G256S mutation that was incorporated into loop 4 (13).
Ca2+-induced Conformational Changes Are Accelerated by Prolyl Isomerase Cyclophilin A
Stopped-flow kinetic analysis of changes in protein tryptophan fluorescence has previously been used to identify the presence of prolyl trans-cis isomerization accompanying Ca2+ binding to C-type lectins (37). To determine whether this was occurring with derCD23, Ca2+-free derCD23 and Ca2+ were mixed in a stopped-flow experiment (Fig. 5). This revealed biphasic kinetics as follows: an initial fast but low amplitude quench followed by a slower quench that dominated the overall fluorescence change. Comparison with studies of MBL (37) suggests that the fast phase reports on the Ca2+-binding step and the slower phase the prolyl isomerization. Consistent with this is the observation that repeating the experiment in the presence of cylophilin A, a prolyl isomerase, accelerated the observed rate constant for the slower step (supplemental Fig. S6), as seen for Ca2+ binding to MBL (37).
Ca2+-induced Ordered Loop 4 of derCD23 Makes Additional Interactions with IgE Fcϵ3-4
The Ca2+-bound derCD23-Fcϵ3-4 complex crystallized in essentially the same crystal form as the previously reported Ca2+-free complex (15), but with a 2% increase in the length of the c-axis. The packing arrangements of the molecules within the two lattices are virtually identical. Data processing and structural determination statistics for the Ca2+-bound complex are presented in Table 1.
In the derCD23-Fcϵ3-4 complex structure, there are three independent complexes per asymmetric unit. The six heavy chains of Fcϵ3-4 (labeled A–F) are bound to six derCD23 molecules (labeled G–L). A single derCD23-Fcϵ3-4 complex (comprising dimeric Fcϵ3-4 chains C and D, bound to derCD23 head domains I and J) is depicted in Fig. 6.
Fcϵ3-4 is in a very “closed” conformation (15, 38) when bound to derCD23. The angle between the Cϵ3 and Cϵ4 domains in the Ca2+-bound derCD23-Fcϵ3-4 complex differ by only 5°, similar to the range observed in the Ca2+-free complex structure. This closed conformation allosterically precludes binding to FcϵRI (15, 39).
The derCD23 molecules within the Ca2+-bound derCD23-Fcϵ3-4 complex presented here are essentially identical, with Cα root mean square deviations ranging from 0.21 to 0.27 Å (over 120 Cα pairs). Each of the six derCD23 molecules has a Ca2+ ion bound at the principal binding site; the electron density for the ion is clear in four of the molecules but is ambiguous in copies H and K. Comparison of the derCD23 molecules from the Ca2+-free and Ca2+-bound complexes shows that the only substantial difference involves residues Ser-256 and Glu-257 of loop 4, for which no electron density was observed in the Ca2+-free complex (15). In contrast, electron density is observed for the entire loop, including residues Ser-256 and Glu-257, in all six copies of derCD23 in the Ca2+-bound complex.
Turning to the interface between derCD23 and Fcϵ3-4, which is almost identical in all six copies in the Ca2+-bound complex, there are a number of differences compared with the Ca2+-free complex (15), all involving loop 4 and its immediate vicinity (Fig. 6 and supplemental Fig. S7). All four salt bridges and two of the four additional hydrogen bonds observed in the Ca2+-free complex (15) are retained in the Ca2+-bound complex; the two hydrogen bonds lost are between Ser-254 (derCD23) and Arg-440 (Fcϵ3-4). However, in the Ca2+-bound complex, there are two additional salt bridges (both Asp-227 and Asp-258 with Arg-440) and two new hydrogen bonds formed (Gln-255 to Arg-440 and Cys-273 to Ser-437) (Fig. 6B). Arg-440, in the Cϵ3-Cϵ4 linker region, is key to these additional interactions with Asp-227 (loop 1) and Asp-258 (loop 4) following Ca2+-induced ordering and conformational change in loop 4.
This involvement of Asp-258 is particularly intriguing because it is the only conserved residue of the auxiliary binding site that remains in human CD23 (supplemental Fig. S8). Thus, although Ca2+ binds only at the principal binding site, it induces conformational changes that bring into play Asp-258 from the auxiliary site, which then makes additional contacts with IgE to enhance the affinity.
A final observation based upon inspection of conformational changes in loops 1 and 4 of both Ca2+-bound and -free complex structures suggests that the Ca2+ ion appears to be able to bind to CD23 either before or after engagement of IgE.
DISCUSSION
Although CD23 recognizes IgE through its CTLD “head,” this interaction does not involve carbohydrate (14) and occurs in the absence of Ca2+, although Ca2+ substantially enhances the affinity (17). In mouse, the IgE/CD23 interaction is reported to be Ca2+-dependent (16), but murine CD23 may differ in its Ca2+-binding ability, since both the “principal” and “auxiliary” Ca2+-binding sites (with reference to MBL, which binds two Ca2+ ions (40)) are conserved (supplemental Fig. S7). Only the principal Ca2+ site is fully conserved in human CD23, but previous structural studies on soluble derCD23 had identified conflicting locations for the binding of a single Ca2+ ion. The NMR solution structure of derCD23, together with chemical shift perturbation measurements, suggested that Ca2+ binds only at the auxiliary binding site (17), but subsequent crystallographic analysis of a double mutant of derCD23 (H213R and G256S) showed Ca2+ bound solely at the principal site (13).
To resolve the controversy, the crystal structure of Ca2+-bound wild-type human derCD23 was solved. Several single point mutations in both the principal and auxiliary binding sites of derCD23 were also generated; their crystal structures were solved, and their ability in solution to bind calcium was assessed by ITC. The structure of Ca2+-bound derCD23 reported here shows a single ion bound at the principal calcium site, liganded by Glu-249, Thr-251, Asp-270, and three water molecules; the KD is 1.5 mm. Ca2+ binding to the mutant derCD23 molecules (E249A and D270A, principal; S252A and D258A, auxiliary) was consistent with binding only to the principal site, with the exception of D258A, which showed no Ca2+ binding (Table 2). However, the crystal structure of this mutant, in contrast to the other three structures that all showed perturbations only at the site of mutation, revealed that the D258A mutation (at the base of loop 4) caused a major reorientation of Arg-253 such that its guanidinium group occupied the principal Ca2+-binding site (supplemental Fig. S4). (A similar reorientation of Arg-253 was reported in the earlier double mutant derCD23 Ca2+-free crystal structure (13), caused there, presumably, by the G256S mutation at the center of loop 4).
Although the results presented here agree with the earlier crystal structure in terms of the location of the single Ca2+ ion (13), the nature of the coordination differs; the earlier study identified Asn-269 as a direct ligand, and the present study indicates that this conserved residue is not a ligand, although it forms a hydrogen bond to one of the Ca2+-ligating water molecules (Fig. 4). The noncritical role of Asn-269 was confirmed by the fact that the mutation N269D left Ca2+-binding unaffected, and the N269A mutation even enhanced affinity (Table 2); the direct involvement of Asn-269 in the earlier structure may be another consequence of the G256S mutation (13). The reason why the NMR analysis of derCD23 appeared to show Ca2+ binding at the auxiliary site (17) is probably due to the conformational changes that we observe in loop 1 upon Ca2+ binding to the principal site, but why changes in chemical shift were not observed in the principal Ca2+-binding site remains unclear.
The effect of Ca2+ binding upon the structure of derCD23 is limited to loops 1 and 4 only, although the latter shows greater changes (Fig. 2). In the presence of Ca2+, all loop 4 conformations are essentially similar, and in the absence of Ca2+, the loop adopts either of two different structures. All residues of this loop are defined in both crystal structures, however, in contrast to the earlier double mutant derCD23 study in which the loop was ordered in the absence of Ca2+ but partially disordered in its presence (13). The isomerization state of Pro-250 appears to be a key determinant of the conformation of loop 4, which is found to be either cis or trans in the Ca2+-free structures, but it is locked in cis in Ca2+-bound CD23.
This is consistent with the extensive studies by Ng et al. (19, 37) showing that binding of Ca2+ at the principal site (site 2) of MBL is coupled to a conformational change in loop 4 that involves the trans-cis isomerization of Pro-191, the structural equivalent of Pro-250 in CD23. In the absence of Ca2+, MBL exists as a mixture of two conformers, but binding of Ca2+ traps loop 4 and Pro-191 in the cis form (19); this trapping only occurs when Ca2+ binds at the principal site (site 2 in MBL) and not when Ca2+ binds only to the auxiliary site (site 1 in MBL).
Weis and co-workers (37) complemented these structural studies by monitoring Ca2+ binding to MBL using stopped-flow spectrofluorimetry. This revealed a characteristic biphasic fluorescence change as follows: a fast (∼1 s−1) burst phase followed by a slower conformational change, identified as the trans/cis prolyl isomerization accompanying Ca2+ binding because the observed rate was accelerated in the presence of cyclophilin A.
We performed a similar stopped-flow spectrofluorimetry study of Ca2+ binding to derCD23, and we discovered striking similarities to the MBL results. First, there is a biphasic fluorescence change with observed rates for the two steps close to those seen for MBL (Fig. 5). Second, the observed rate for the slower phase is also accelerated in the presence of the prolyl isomerase cyclophilin A. This suggests that Ca2+ binding triggers a proline isomerization, presumably to the cis form seen in the Ca2+-bound structure.
The binding of Ca2+ to CD23 enables it to make additional interactions with IgE. In the structure of the complex between Ca2+-free derCD23 and Fcϵ3-4, the interface is dominated by four salt bridges and four additional hydrogen bonds (15). Loop 4, immediately adjacent to the interface, is disordered at residues Ser-256 and Glu-257. The structure of the complex that we now report here, in the presence of Ca2+, is virtually identical in all regards except for the structure of loop 4, which is fully ordered (Fig. 6). The consequence of this Ca2+-induced structural change is that two additional salt bridges are made, as well as two new hydrogen bonds, although two that were present in the Ca2+-free structure are lost (Fig. 6B). These additional salt bridges, Asp-227 and Asp-258 with Arg-440, which lie in the Cϵ3-Cϵ4 linker region, undoubtedly make the principal contribution to the enhanced affinity of CD23 for IgE in the presence of Ca2+.
The thermodynamic analysis of the interaction between derCD23 and IgE (Fig. 1) is consistent with the ordering effect of Ca2+ binding on loop 4. In the presence of calcium, the interaction is entropically favorable, and without calcium it is entropically unfavorable. Although there are undoubtedly significant differences in how water and counter ions behave in the Ca2+-bound and Ca2+-free structures, the most obvious structural effect is on the dynamics of loop 4. The greater entropic contribution to binding in the presence of Ca2+ therefore at least partly reflects the smaller entropic penalty upon forming the complex with a more ordered loop 4. The earlier NMR study of derCD23 showed that this loop exhibits substantial mobility when free in solution (17).
Although a single CD23 head domain binds to IgE with a KD of about 1.5 μm (this paper and see Ref. 41), compared with 10−10–10−11 m for FcϵRI, the avidity effect achieved when two or more CD23 heads of the trimeric molecule engage two or more IgE molecules in an immune complex or on the surface of a cell is considerable and may approach that of FcϵRI binding (9, 42–44). Thus, the 30-fold enhancement of CD23 binding to IgE in the presence of Ca2+ could have a profound effect when amplified through avidity.
Ca2+ binds to derCD23 with a KD of 1.5 mm. The physiological concentration of Ca2+ is approximately this value, ranging from 1.0 to 1.3 mm (45), although it can be substantially higher or lower depending on the local intra- or extracellular environment (46). Thus, Ca2+ binding to CD23 may play a critical role in a physiological setting. For example, the interactions between soluble trimeric CD23 and membrane IgE and between IgE-allergen complexes and membrane CD23 have been implicated in the regulation of IgE synthesis in B-cells (2, 9, 10); enhancement of the latter interaction by Ca2+ would also promote facilitated allergen presentation (11). Thus, the binding of Ca2+ brings an extra degree of modulation to CD23 function.
CD23 stands out among the Ig receptors as a member of a different superfamily, and although binding to human IgE does not require either carbohydrate or Ca2+, the latter does contribute to its activity, as we have seen, through binding at one of the CTLD's evolutionarily conserved sites. It is therefore particularly intriguing that, at least in human CD23, an amino acid side chain associated with binding a second Ca2+ ion in other CTLDs, Asp-258 (supplemental Fig. S8), has been conserved in CD23 and “co-opted” into making an additional interaction with IgE (Fig. 6B). In human CD23, the other auxiliary Ca2+ site residues have not been conserved, but in murine CD23 (and in several other species), the auxiliary site ligands are conserved, and binding of a second Ca2+ ion is predicted. It is unclear how this might affect IgE binding, but the effect of Ca2+ will certainly differ; indeed, the early report of a requirement for Ca2+ in the murine system is pertinent (16). Human CD23 differs from murine CD23 in other respects too, such as its interactions with CD21, which does not occur in the murine system (2). Many aspects of the role of CD23 in allergy may therefore be a relatively recent evolutionary development, but understanding its subtleties, such as the part played by Ca2+, may inform attempts to develop modulatory molecules for therapeutic purposes.
Supplementary Material
This work was supported by the Wellcome Trust, Asthma UK, the Medical Research Council (United Kingdom), and Diamond Light Source.
This article contains supplemental Figs. S1–S8, Tables S1 and S2, and additional references.
- CTLD
- C-type lectin-like domain
- MBL
- mannose-binding lectin
- ITC
- isothermal titration calorimetry
- BisTris propane
- 1,3-bis[tris(hydroxymethyl)methylamino]propane
- PDB
- Protein Data Bank.
REFERENCES
- 1. Finkelman F. D., Vercelli D. (2007) Advances in asthma, allergy mechanisms, and genetics in 2006. J. Allergy Clin. Immunol. 120, 544–550 [DOI] [PubMed] [Google Scholar]
- 2. Gould H. J., Sutton B. J. (2008) IgE in allergy and asthma today. Nat. Rev. Immunol. 8, 205–217 [DOI] [PubMed] [Google Scholar]
- 3. Zelensky A. N., Gready J. E. (2003) Comparative analysis of structural properties of the C-type-lectin-like domain (CTLD). Proteins 52, 466–477 [DOI] [PubMed] [Google Scholar]
- 4. Zelensky A. N., Gready J. E. (2005) The C-type lectin-like domain superfamily. FEBS J. 272, 6179–6217 [DOI] [PubMed] [Google Scholar]
- 5. Beavil A. J., Edmeades R. L., Gould H. J., Sutton B. J. (1992) α-Helical coiled-coil stalks in the low-affinity receptor for IgE (Fc epsilon RII/CD23) and related C-type lectins. Proc. Natl. Acad. Sci. U.S.A. 89, 753–757 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Lemieux G. A., Blumenkron F., Yeung N., Zhou P., Williams J., Grammer A. C., Petrovich R., Lipsky P. E., Moss M. L., Werb Z. (2007) The low affinity IgE receptor (CD23) is cleaved by the metalloproteinase ADAM10. J. Biol. Chem. 282, 14836–14844 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Weskamp G., Ford J. W., Sturgill J., Martin S., Docherty A. J., Swendeman S., Broadway N., Hartmann D., Saftig P., Umland S., Sehara-Fujisawa A., Black R. A., Ludwig A., Becherer J. D., Conrad D. H., Blobel C. P. (2006) ADAM10 is a principal “sheddase” of the low-affinity immunoglobulin E receptor CD23. Nat. Immunol. 7, 1293–1298 [DOI] [PubMed] [Google Scholar]
- 8. Schulz O., Sutton B. J., Beavil R. L., Shi J., Sewell H. F., Gould H. J., Laing P., Shakib F. (1997) Cleavage of the low-affinity receptor for human IgE (CD23) by a mite cysteine protease: nature of the cleaved fragment in relation to the structure and function of CD23. Eur. J. Immunol. 27, 584–588 [DOI] [PubMed] [Google Scholar]
- 9. McCloskey N., Hunt J., Beavil R. L., Jutton M. R., Grundy G. J., Girardi E., Fabiane S. M., Fear D. J., Conrad D. H., Sutton B. J., Gould H. J. (2007) Soluble CD23 monomers inhibit and oligomers stimulate IGE synthesis in human B cells. J. Biol. Chem. 282, 24083–24091 [DOI] [PubMed] [Google Scholar]
- 10. Cooper A. M., Hobson P. S., Jutton M. R., Kao M. W., Drung B., Schmidt B., Fear D. J., Beavil A. J., McDonnell J. M., Sutton B. J., Gould H. J. (2012) Soluble CD23 controls IgE synthesis and homeostasis in human B cells. J. Immunol. 188, 3199–3207 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Carlsson F., Hjelm F., Conrad D. H., Heyman B. (2007) IgE enhances specific antibody and T-cell responses in mice overexpressing CD23. Scand. J. Immunol. 66, 261–270 [DOI] [PubMed] [Google Scholar]
- 12. Natarajan K., Dimasi N., Wang J., Mariuzza R. A., Margulies D. H. (2002) Structure and function of natural killer cell receptors: multiple molecular solutions to self, nonself discrimination. Annu. Rev. Immunol. 20, 853–885 [DOI] [PubMed] [Google Scholar]
- 13. Wurzburg B. A., Tarchevskaya S. S., Jardetzky T. S. (2006) Structural changes in the lectin domain of CD23, the low-affinity IgE receptor, upon calcium binding. Structure 14, 1049–1058 [DOI] [PubMed] [Google Scholar]
- 14. Vercelli D., Helm B., Marsh P., Padlan E., Geha R. S., Gould H. (1989) The B-cell binding site on human immunoglobulin E. Nature 338, 649–651 [DOI] [PubMed] [Google Scholar]
- 15. Dhaliwal B., Yuan D., Pang M. O., Henry A. J., Cain K., Oxbrow A., Fabiane S. M., Beavil A. J., McDonnell J. M., Gould H. J., Sutton B. J. (2012) Crystal structure of IgE bound to its B-cell receptor CD23 reveals a mechanism of reciprocal allosteric inhibition with high affinity receptor FcϵRI. Proc. Natl. Acad. Sci. U.S.A. 109, 12686–12691 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Richards M. L., Katz D. H. (1990) The binding of IgE to murine FcϵRII is calcium-dependent but not inhibited by carbohydrate. J. Immunol. 144, 2638–2646 [PubMed] [Google Scholar]
- 17. Hibbert R. G., Teriete P., Grundy G. J., Beavil R. L., Reljic R., Holers V. M., Hannan J. P., Sutton B. J., Gould H. J., McDonnell J. M. (2005) The structure of human CD23 and its interactions with IgE and CD21. J. Exp. Med. 202, 751–760 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Bettler B., Texido G., Raggini S., Rüegg D., Hofstetter H. (1992) Immunoglobulin E-binding site in Fcϵ receptor (FcϵRII/CD23) identified by homolog-scanning mutagenesis. J. Biol. Chem. 267, 185–191 [PubMed] [Google Scholar]
- 19. Ng K. K., Park-Snyder S., Weis W. I. (1998) Ca2+-dependent structural changes in C-type mannose-binding proteins. Biochemistry 37, 17965–17976 [DOI] [PubMed] [Google Scholar]
- 20. Myszka D. G. (2000) Kinetic, equilibrium, and thermodynamic analysis of macromolecular interactions with BIACORE. Methods Enzymol. 323, 325–340 [DOI] [PubMed] [Google Scholar]
- 21. Powell H. R. (1999) The Rossmann Fourier autoindexing algorithm in MOSFLM. Acta Crystallogr. D Biol. Crystallogr. 55, 1690–1695 [DOI] [PubMed] [Google Scholar]
- 22. Battye T. G., Kontogiannis L., Johnson O., Powell H. R., Leslie A. G. (2011) iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM. Acta Crystallogr. D Biol. Crystallogr. 67, 271–281 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Otwinowski Z., Minor W. (1997) Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307–326 [DOI] [PubMed] [Google Scholar]
- 24. McCoy A. J., Grosse-Kunstleve R. W., Adams P. D., Winn M. D., Storoni L. C., Read R. J. (2007) Phaser crystallographic software. J. Appl. Crystallogr. 40, 658–674 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Fabiola F., Korostelev A., Chapman M. S. (2006) Bias in cross-validated free R factors: mitigation of the effects of noncrystallographic symmetry. Acta Crystallogr. D Biol. Crystallogr. 62, 227–238 [DOI] [PubMed] [Google Scholar]
- 26. Winn M. D., Ballard C. C., Cowtan K. D., Dodson E. J., Emsley P., Evans P. R., Keegan R. M., Krissinel E. B., Leslie A. G., McCoy A., McNicholas S. J., Murshudov G. N., Pannu N. S., Potterton E. A., Powell H. R., Read R. J., Vagin A., Wilson K. S. (2011) Overview of the CCP4 suite and current developments. Acta Crystallogr. D Biol. Crystallogr. 67, 235–242 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Murshudov G. N., Skubák P., Lebedev A. A., Pannu N. S., Steiner R. A., Nicholls R. A., Winn M. D., Long F., Vagin A. A. (2011) REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr. D Biol. Crystallogr. 67, 355–367 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Adams P. D., Afonine P. V., Bunkóczi G., Chen V. B., Echols N., Headd J. J., Hung L. W., Jain S., Kapral G. J., Grosse Kunstleve R. W., McCoy A. J., Moriarty N. W., Oeffner R. D., Read R. J., Richardson D. C., Richardson J. S., Terwilliger T. C., Zwart P. H. (2011) The Phenix software for automated determination of macromolecular structures. Methods 55, 94–106 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Smart O. S., Womack T. O., Flensburg C., Keller P., Paciorek W., Sharff A., Vonrhein C., Bricogne G. (2012) Exploiting structure similarity in refinement: automated NCS and target-structure restraints in BUSTER. Acta Crystallogr. D Biol. Crystallogr. 68, 368–380 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Emsley P., Lohkamp B., Scott W. G., Cowtan K. (2010) Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486–501 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Painter J., Merritt E. A. (2006) Optimal description of a protein structure in terms of multiple groups undergoing TLS motion. Acta Crystallogr. D Biol. Crystallogr. 62, 439–450 [DOI] [PubMed] [Google Scholar]
- 32. Painter J., Merritt E. A. (2005) A molecular viewer for the analysis of TLS rigid-body motion in macromolecules. Acta Crystallogr. D Biol. Crystallogr. 61, 465–471 [DOI] [PubMed] [Google Scholar]
- 33. Schrödinger L. (2011) The PyMOL Graphics System, Version 1.5.0, Schrödinger, LLC, New York [Google Scholar]
- 34. Weis W. I., Drickamer K., Hendrickson W. A. (1992) Structure of a C-type mannose-binding protein complexed with an oligosaccharide. Nature 360, 127–134 [DOI] [PubMed] [Google Scholar]
- 35. Feinberg H., Castelli R., Drickamer K., Seeberger P. H., Weis W. I. (2007) Multiple modes of binding enhance the affinity of DC-SIGN for high mannose N-linked glycans found on viral glycoproteins. J. Biol. Chem. 282, 4202–4209 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Meier M., Bider M. D., Malashkevich V. N., Spiess M., Burkhard P. (2000) Crystal structure of the carbohydrate recognition domain of the H1 subunit of the asialoglycoprotein receptor. J. Mol. Biol. 300, 857–865 [DOI] [PubMed] [Google Scholar]
- 37. Ng K. K., Weis W. I. (1998) Coupling of prolyl peptide bond isomerization and Ca2+ binding in a C-type mannose-binding protein. Biochemistry 37, 17977–17989 [DOI] [PubMed] [Google Scholar]
- 38. Wurzburg B. A., Jardetzky T. S. (2009) Conformational flexibility in immunoglobulin E-Fc 3–4 revealed in multiple crystal forms. J. Mol. Biol. 393, 176–190 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Borthakur S., Hibbert R. G., Pang M. O., Yahya N., Bax H. J., Kao M. W., Cooper A. M., Beavil A. J., Sutton B. J., Gould H. J., McDonnell J. M. (2012) Mapping of the CD23 binding site on immunoglobulin E (IgE) and allosteric control of the IgE-Fc ϵRI interaction. J. Biol. Chem. 287, 31457–31461 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Weis W. I., Kahn R., Fourme R., Drickamer K., Hendrickson W. A. (1991) Structure of the calcium-dependent lectin domain from a rat mannose-binding protein determined by MAD phasing. Science 254, 1608–1615 [DOI] [PubMed] [Google Scholar]
- 41. Shi J., Ghirlando R., Beavil R. L., Beavil A. J., Keown M. B., Young R. J., Owens R. J., Sutton B. J., Gould H. J. (1997) Interaction of the low-affinity receptor CD23/Fc ϵRII lectin domain with the Fc ϵ3–4 fragment of human immunoglobulin E. Biochemistry 36, 2112–2122 [DOI] [PubMed] [Google Scholar]
- 42. Dierks S. E., Bartlett W. C., Edmeades R. L., Gould H. J., Rao M., Conrad D. H. (1993) The oligomeric nature of the murine Fc ϵRII/CD23. Implications for function. J. Immunol. 150, 2372–2382 [PubMed] [Google Scholar]
- 43. Kelly A. E., Chen B. H., Woodward E. C., Conrad D. H. (1998) Production of a chimeric form of CD23 that is oligomeric and blocks IgE binding to the Fc ϵRI. J. Immunol. 161, 6696–6704 [PubMed] [Google Scholar]
- 44. Chen B. H., Ma C., Caven T. H., Chan-Li Y., Beavil A., Beavil R., Gould H., Conrad D. H. (2002) Necessity of the stalk region for immunoglobulin E interaction with CD23. Immunology 107, 373–381 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Larsson L., Ohman S. (1978) Serum ionized calcium and corrected total calcium in borderline hyperparathyroidism. Clin. Chem. 24, 1962–1965 [PubMed] [Google Scholar]
- 46. Petersen O. H. (2002) Calcium signal compartmentalization. Biol. Res. 35, 177–182 [DOI] [PubMed] [Google Scholar]
- 47. Atkins P. (2001) The Elements of Physical Chemistry, 3rd Ed., Oxford University Press, Oxford, UK [Google Scholar]
- 48. Naghibi H., Tamura A., Sturtevant J. M. (1995) Significant discrepancies between van't Hoff and calorimetric enthalpies. Proc. Natl. Acad. Sci. U.S.A. 92, 5597–5599 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Weiss M. S. (2001) Global indicators of X-ray data quality. J. Appl. Crystallogr. 34, 130–135 [Google Scholar]
- 50. Chen V. B., Arendall W. B., 3rd, Headd J. J., Keedy D. A., Immormino R. M., Kapral G. J., Murray L. W., Richardson J. S., Richardson D. C. (2010) MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D Biol. Crystallogr. 66, 12–21 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.